ym 264 has been researched along with thiazoles in 7 studies
| Studies (ym 264) | Trials (ym 264) | Recent Studies (post-2010) (ym 264) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 33,179 | 2,100 | 12,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
| Arima, M; Fukuda, T; Makino, S; Manaka, K | 1 |
| Arima, M; Makino, S; Yukawa, T | 1 |
| Bird, IN; Daniels, RH; Elmore, MA; Finnen, MJ; Hill, ME | 1 |
| Hara, H; Mase, T; Matsuhisa, A; Nagaoka, H; Saito, M; Suzuki, T; Takahashi, T; Takeuchi, M; Tomioka, K; Yamada, T | 1 |
| Miyata, K; Umeda, M; Yamada, T; Yamano, M | 1 |
| Hara, H; Mase, T; Matsumoto, H; Nagaoka, H; Saito, M; Suzuki, T; Takanuki, K; Takeuchi, M; Tomioka, K; Yamada, T | 1 |
7 other study(ies) available for ym 264 and thiazoles
| Article | Year |
|---|---|
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |
Role of platelet-activating factor in the release of neutrophil and eosinophil chemotactic attractants from cultured guinea-pig tracheal epithelial cells.
Topics: Animals; Chemotactic Factors; Eosinophils; Epithelial Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Guinea Pigs; Male; Neutrophils; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thiazolidines; Trachea | 1995 |
Effect of YM264 on the airway hyperresponsiveness and the late asthmatic response in a guinea pig model of asthma.
Topics: Aerosols; Airway Resistance; Analysis of Variance; Animals; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Guinea Pigs; Immunization; Male; Ovalbumin; Piperazines; Platelet Activating Factor; Random Allocation; Statistics, Nonparametric; Thiazoles; Thiazolidines; Time Factors; Trachea | 1995 |
Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
Topics: Arachidonic Acid; Azepines; Cell Adhesion; Cell Movement; Cell Polarity; Endothelium, Vascular; Humans; In Vitro Techniques; Interleukin-1; Neutrophil Activation; Neutrophils; Piperazines; Platelet Activating Factor; Superoxides; Thiazoles; Thiazolidines; Triazoles | 1994 |
2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Topics: Animals; Capillary Permeability; Guinea Pigs; Hematocrit; Humans; Mice; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rabbits; Rats; Rats, Wistar; Species Specificity; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1997 |
Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
Topics: Alanine Transaminase; Amylases; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Ceruletide; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kidney; Leukocyte Elastase; Lipase; Lipopolysaccharides; Liver; Lung; Male; Multiple Organ Failure; Organ Size; Pancreas; Pancreatitis; Piperazines; Platelet Membrane Glycoproteins; Pyridones; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfonamides; Survival Rate; Thiazoles; Thiazolidines; Time Factors | 1998 |
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists.
Topics: Administration, Oral; Animals; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Dogs; In Vitro Techniques; Injections, Intravenous; Macaca mulatta; Male; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridines; Rabbits; Rats; Rats, Inbred F344; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thiazolidines | 1999 |